Three Molecular Structures Cause Rhesus D Category VI Phenotypes With Distinct Immunohematologic Features
Open Access
- 15 March 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 91 (6) , 2157-2168
- https://doi.org/10.1182/blood.v91.6.2157.2157_2157_2168
Abstract
Rhesus D category VI (DVI) is the clinically most important partial D. DVI red blood cells were assumed to possess very low RhD antigen density and to be caused by twoRHD-CE-D hybrid alleles. Because there was no population-based work-up, we screened three populations in central Europe for DVI. Twenty-six DVI samples were detected and examined by exon-specific RHD polymerase chain reaction with sequence-specific primers (PCR-SSP). A new genotype, hereby designated D category VI type III, was characterized as a RHD-Ce(3-6)-D hybrid allele by sequencing of the cDNA, parts of intron 1, and by PCR-restriction fragment length polymorphism (PCR-RFLP) of intron 2. Rhesus introns 5 and 6 were sequenced and the 3′ breakpoints of all knownDVItypes shown to be distinct. We differentiated the 5′ breakpoints of DVItypeI andDVItype II by a newly devised RHD-PCR. Thus, the DVI phenotype originated in at least three independent molecular events. Each DVI type showed distinct immunohematologic features in flow cytometry. The number of RhD proteins accessible on the red blood cells' surface ofDVItype III was normal (about 12,000 antigens/cell; DVItypeI, 500;DVItype II, 2,400) based on the determination of an RhD epitope density profile. DVItype II and DVItype III occurred as CDe haplotypes, and DVItype I as a cDE haplotype.The distribution of the DVItypes varied significantly in three German-speaking populations. Genotyping strategies should take account of allelic variations in partial RhD. The reconsideration of previous serologic and clinical data for partial D in view of the underlying molecular structures may be worthwhile.Keywords
This publication has 47 references indexed in Scilit:
- Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D proteinBritish Journal of Haematology, 1997
- Polymorphism of the h allele and the population frequency of sporadic nonfunctional allelesTransfusion, 1997
- Involvement of Ser103 of the Rh polypeptides in G epitope formationTransfusion, 1996
- Frequencies of the Blood Groups ABO, Rhesus, D Category VI, Kell, and of Clinically Relevant High-Frequency Antigens in South-Western GermanyTransfusion Medicine and Hemotherapy, 1995
- Influence of Rh phenotype on the antigen density of C, c, and D: flow cytometric study using a frozen standard red cellTransfusion, 1994
- Organization of the Gene (RHCE) Encoding the Human Blood Group RhCcEe Antigens and Characterization of the Promoter RegionGenomics, 1994
- Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti‐DTransfusion Medicine, 1993
- Variation in the level of Rh(D) antigen expressionTransfusion, 1988
- Quantitative studies on the Rh‐antigen DTransfusion, 1987
- A successful program of immunizing Rh‐negative male volunteers for anti‐ D production using frozen/thawed bloodTransfusion, 1981